The effect of oxidized low-density lipoprotein combined with adriamycin on the proliferation of Eca-109 cell line
2011
Effects of Oxidized LDL and Adriamycin on Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): Li Hao, Li Qing D, Wang Ping Zhi, Wang Mei Shu, Cui Jia, Diao Tao Yu, Li Qing Hui
Primary Institution: Qilu Hospital, Shandong University
Hypothesis
The study investigates the role of oxidized low-density lipoprotein (oxLDL) combined with adriamycin (ADM) in inducing apoptosis in Eca-109 cells.
Conclusion
OxLDL has cytotoxic effects and enhances apoptosis in Eca-109 cells when combined with ADM.
Supporting Evidence
- OxLDL was found to be cytotoxic and activated apoptosis in Eca-109 cells.
- The combination of oxLDL and ADM significantly increased the rate of apoptosis.
- The expression of the anti-apoptotic gene Bcl-2 was downregulated, while pro-apoptotic genes Bax and Caspase-3 were upregulated.
Takeaway
This study found that a substance called oxidized LDL can help kill cancer cells when used with a cancer drug called adriamycin.
Methodology
Eca-109 cells were treated with oxLDL and ADM, and cell proliferation and apoptosis were assessed using MTT assays and flow cytometry.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website